Therefore, further studies should evaluate the translational potential of observed BDNF alternations as blood-based biomarkers for clinical diagnosis and monitoring of dementia, as well as the possible usefulness of BDNF replacement in cognitive disorders. The gene discussed is BDNF; the disease is Cognitive impairment.